Cambridge Investment Research Advisors
PPH icon

Cambridge Investment Research Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

Cambridge Investment Research Advisors’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$469K Buy
4,289
+681
+19% +$70.5K ﹤0.01% 3026
2026
Q1 		$375K Buy
3,608
+444
+14% +$47.3K ﹤0.01% 3072
2025
Q4 		$326K Sell
3,164
-210
-6% -$20.4K ﹤0.01% 3117
2025
Q3 		$305K Buy
3,374
+221
+7% +$19.4K ﹤0.01% 3099
2025
Q2 		$277K Sell
3,153
-236
-7% -$20.5K ﹤0.01% 3051
2025
Q1 		$309K Sell
3,389
-32
-0.9% -$2.88K ﹤0.01% 2845
2024
Q4 		$295K Sell
3,421
-40,792
-92% -$3.69M ﹤0.01% 2845
2024
Q3 		$4.2M Buy
44,213
+39,385
+816% +$3.74M 0.01% 902
2024
Q2 		$442K Buy
4,828
+1,981
+70% +$177K ﹤0.01% 2392
2024
Q1 		$258K Buy
+2,847
New +$249K ﹤0.01% 2827
2023
Q3 		– Sell
-9,802
Closed -$772K – 3238
2023
Q2 		$772K Buy
9,802
+3,228
+49% +$253K ﹤0.01% 1799
2023
Q1 		$510K Sell
6,574
-20,019
-75% -$1.54M ﹤0.01% 2063
2022
Q4 		$2.07M Buy
26,593
+23,339
+717% +$1.72M 0.01% 1061
2022
Q3 		$219K Sell
3,254
-767
-19% -$56.5K ﹤0.01% 2626
2022
Q2 		$309K Buy
+4,021
New +$314K ﹤0.01% 2359

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Cambridge Investment Research Advisors's PPH Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its VanEck Pharmaceutical ETF (PPH) stake by 19% in Q2 2026, buying an estimated $70.5K and bringing the position to 4,289 shares worth $469K. The position accounts for ﹤0.01% of the portfolio, ranked #3026.

Cambridge Investment Research Advisors first reported a position in PPH in Q2 2022 and has held it in 15 quarters since. The position peaked at $4.2M in Q3 2024. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Cambridge Investment Research Advisors held 4,289 shares of VanEck Pharmaceutical ETF worth $469K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 681 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $70.5K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3026 holding.
  • Cambridge Investment Research Advisors first reported a position in VanEck Pharmaceutical ETF in Q2 2022 and has held it in 15 quarters since.
  • Cambridge Investment Research Advisors's VanEck Pharmaceutical ETF position peaked at $4.2M in Q3 2024.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.